AMX-883
Asset
Promotes targeted protein degradation through a mechanism independent of cereblon and VHL.
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- Not known
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Acute myeloid leukemia
Phase 1, businesswire.com, 12 Oct 2026
In the full profile
- Owner and partners1
- Competitors2
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.